Cargando…
Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus
Mycobacterium abscessus (M. abscessus) causes chronic pulmonary infections and is the most difficult non-tuberculous mycobacteria (NTM) to treat due to its resistance to current antimicrobial drugs, with a treatment success rate of 45.6%. Thus, novel treatment drugs are needed, of which we identifie...
Autores principales: | Lee, Da-Gyum, Hwang, Yoo-Hyun, Park, Eun-Jin, Kim, Jung-Hyun, Ryoo, Sung-Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537717/ https://www.ncbi.nlm.nih.gov/pubmed/34681686 http://dx.doi.org/10.3390/ijms222011029 |
Ejemplares similares
-
10-DEBC Hydrochloride as a Promising New Agent against Infection of Mycobacterium abscessus
por: Lee, Da-Gyum, et al.
Publicado: (2022) -
Metformin—clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
por: Ayaz, Aqueela, et al.
Publicado: (2013) -
Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
por: Kim, Tae Ho, et al.
Publicado: (2019) -
Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome
por: Amirian, Maliheh, et al.
Publicado: (2021)